메뉴 건너뛰기




Volumn 40, Issue 1, 2000, Pages 49-57

Repaglinide in type 2 diabetes: A 24-week, fixed-dose efficacy and safety study

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; PLACEBO; REPAGLINIDE;

EID: 0033694392     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/00912700022008694     Document Type: Article
Times cited : (91)

References (14)
  • 1
    • 0029089364 scopus 로고
    • The esters of carboxylic nutrients as insulinotropic tools in non-insulin-dependent diabetes mellitus
    • (1995) Gen Pharmacol , vol.26 , Issue.6 , pp. 1133-1141
    • Malaisse, W.J.1
  • 6
    • 0029817751 scopus 로고    scopus 로고
    • Modulation of insulin secretion in non-insulin-dependent diabetes mellitus by two novel oral hypoglycemic agents, NN623 and A4166
    • (1996) Diabetic Med , vol.13 , pp. S151-S155
    • Kikuchi, M.1
  • 7
    • 0007143021 scopus 로고    scopus 로고
    • Physician's Desk Reference. 53rd ed. Montvale, NJ: Medical Economics Company
    • (1999) , pp. 2107-2110
  • 11
    • 0001000706 scopus 로고    scopus 로고
    • Repaglinide, a new rapid and short-acting non-sulphonylurea insulin secretagogue inhibits ATP-sensitive potassium channels (IK(ATP)) in isolated heart muscle cells
    • (1997) Diabetologia , vol.40 , pp. A324
    • Diederen, W.1    Kolb, W.2
  • 12
    • 0030034518 scopus 로고    scopus 로고
    • UK Prospective Diabetes Study 17: A nine-year update of a randomized, controlled trial on the effect of improved glycemic control on complications in non-insulin-dependent diabetes mellitus
    • (1996) Ann Intern Med , vol.124 , Issue.1 , pp. 136-145


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.